Session Information

HomeProgramSession Information ▶ Educational Grant Support Acknowledgements
Educational Grant Support Acknowledgements

The American Thoracic Society gratefully acknowledges the following companies for educational and in-kind grant support of its educational programming. All CME sessions have been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) and are free of the control of commercial interests.

All grants are developed and submitted after content is approved and programmed by the ATS International Conference Committee. All granting relationships are between the companies that support education and the American Thoracic Society, and are within the Standards for Commercial Support from the American Council for Continuing Medical Education and the Council of Medical Specialty Societies Code of Conduct, which the ATS signed in October 2010.

The following companies have provided educational grants in support of courses offered at ATS 2018. Please see details for all specific courses supported by these companies.**Companies providing $100,000 or more in educational grant support are noted in bold text.

  • Actelion Pharmaceuticals US, Inc.
  • AstraZeneca LP
  • Bayer US
  • Boston Scientific Corporation
  • Boehringer Ingelheim Pharmaceuticals, Inc.    
  • Genentech
  • Gilead Sciences, Inc.
  • GlaxoSmithKline
  • Insmed Incorporated
  • Mallinckrodt Pharmaceuticals
  • Olympus Corporation of the Americas
  • Sanofi Genzyme and Regeneron Pharmaceuticals
  • Sunovion Pharmaceuticals, Inc.
  • Vertex Pharmaceuticals, Inc.

 

The following companies have provided in-kind support by loaning equipment or donating materials for use in educational courses offered at ATS 2018. Please see details for specific courses supported. **Companies supporting more than one course are noted in bold text.

  • Abbott Laboratories
  • Agilent Technologies
  • Ambu
  • AstraZeneca LP
  • BD
  • Boston Scientific Corporation
  • Boehringer Ingelheim Pharmaceuticals, Inc.
  • Clement Clark International
  • Cook Medical
  • Edwards Lifesciences LLC
  • ERBE USA, Inc.
  • Fisher & Paykel Healthcare
  • FUJIFILM Medical Systems, USA, Inc.
  • FUJIFILM Sonosite, Inc.
  • GE Healthcare
  • Getinge
  • GlaxoSmithKline
  • Hill-Rom
  • Medtronic
  • MicroDirect, Inc.
  • Mohaghan Medical
  • ndd Medical Technologies
  • Olympus Corporation of the Americas
  • Philips Respironics
  • ResMed
  • Smiths Medical
  • Sunovion Pharmaceuticals, Inc.
  • Teleflex Medical, Inc.
  • Teva Pharmaceuticals
  • Veran Medical Technologies
  • Verathon
  • Vyaire

 


Educational Grant Support By Session

The American Thoracic Society would like to thank all of the companies below for their generous support of our educational programming at ATS 2018.

Friday, May 18, 2018

PG1A – “Critical Care Ultrasound and Echocardiography I”
In-Kind Support: Cook Medical, FUJIFILM SonoSite, Inc., GE Healthcare, Philips Respironics, Teleflex Medical, Inc. 

PG1B – “Critical Care Ultrasound and Echocardiography II”
In-Kind Support: Cook Medical, FUJIFILM SonoSite, Inc., GE Healthcare, Philips Respironics, Teleflex Medical, Inc. 

PG2 – “Expanding Horizons in Support for Respiratory Failure: Ecmo and Beyond”
In-Kind Support: Abbott Laboratories, FUJIFILM SonoSite, Inc.

PG3 – “Advanced Pap Therapy: Treatment of Sleep Disordered Breathing Beyond OSA”
In-Kind Support: Fisher & Paykel Healthcare, Philips Respironics, ResMed

PG4 – “Asthma State of the Art 2018”
Educational Grant Support: GlaxoSmithKline, Sanofi Genzyme and Regeneron Pharmaceuticals

PG6 – “Sarcoidosis Update”
Educational Grant Support: Mallinckrodt Pharmaceuticals

PG10 – “Difficult Clinical Problems in Pulmonary and Critical Care Infections”
Educational Grant Support: Insmed Incorporated

PG13 – “Forgotten and Controversial Topics in Pulmonary Vascular Disease”
Educational Grant Support: Actelion Pharmaceuticals US, Inc., Bayer US, Gilead Sciences, Inc.

PG14 – “Are Your Mitochondria Happy? A Beginners Guide to Assessing Mitochondrial Function at the Bench”
In-Kind Support: Agilent Technologies

Saturday, May 19, 2018

PG16 – “Bronch Day: A Comprehensive, Hands-On Guide to Basic Bronchoscopy  and EBUS"
Educational Grant Support: Boston Scientific Corporation, Olympus Corporation of the Americas
In-Kind Support: Boston Scientific Corporation, Cook Medical, Edwards Lifesciences LLC, ERBE USA, Inc., Olympus Corporation of the Americas, Smiths Medical, Teleflex Medical, Inc., Verathon

PG19 – “Interstitial Lung Disease: Update and Evolving Trends in Diagnosis and Management"
Educational Grant Support: Boehringer Ingelheim Pharmaceuticals, Inc.

PG22 – “Bronchiectasis and Adult Cystic Fibrosis: Where Do We Stand Today?”
Educational Grant Support: Insmed Incorporated, Vertex Pharmaceuticals Inc.

PG23 – “Advances in the Diagnosis and Management of Pediatric Severe Asthma”
Educational Grant Support: GlaxoSmithKline, Sanofi Genzyme and Regeneron Pharmaceuticals

PG29 – “State of the Art: Lung Cancer in 2018”
Educational Grant Support: AstraZeneca LP

ATS 2018 Fellows Track Symposium
Educational Grant Support: Actelion Pharmaceuticals US, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., AstraZeneca LP, Genentech, Vertex Pharmaceuticals Inc.
In-Kind Support: FUJIFILM SonoSite, Inc., ndd Medical Technologies

ATS 2018 Resident Boot Camp Program
Educational Grant Support: Olympus Corporation of the Americas
In-Kind Support: Abbott Laboratories, Ambu, AstraZeneca LP, BD, Boehringer Ingelheim Pharmaceuticals, Inc., Clement Clark International, Cook Medical, ERBE USA, Inc., Fisher & Paykel Healthcare, FUJIFILM SonoSite, Inc., Getinge, GlaxoSmithKline, Hill-Rom, Mohaghan Medical, Medtronic, MicroDirect, Olympus Corporation of the Americas, Philips Respironics, Sunovion Pharmaceuticals Inc., Teva Pharmaceuticals, Vyaire               

Sunday, May 20, 2018

A1 – “Clinicial Year in Review 1”
Educational Grant Support: Boehringer Ingelheim Pharmaceuticals, Inc., Boston Scientific Corporation

A7 – “Leveraging Molecular Mechanisms of Granuloma Formation in Sarcoidosis to Improve Care”
Educational Grant Support: Mallinckrodt Pharmaceuticals

A8 – “Current Controversies in PAH Disease Mechanisms: A Pro-Con Debate”
Educational Grant Support: Actelion Pharmaceuticals US, Inc., Bayer US, Gilead Sciences, Inc.

A11 – “ATS/JRS/CTS/ERS Symposium on Severe Asthma: Rationalizing Targeted Therapeutics”
Educational Grant Support: GlaxoSmithKline, Sanofi Genzyme and Regeneron Pharmaceuticals

A13 – “ATS/ALA Implementation Guide for Lung Screening : An Operational Toolkit”
Educational Grant Support: AstraZeneca LP

A81 – “Pediatric Year in Review”
Educational Grant Support: GlaxoSmithKline, Sanofi Genzyme and Regeneron Pharmaceuticals, Vertex Pharmaceuticals Inc.

A82 – “Reaching for the Gold: Addressing Gaps in the 2017 GOLD Guidelines”
Educational Grant Support: AstraZeneca LP, GlaxoSmithKline, Sunovion Pharmaceuticals Inc.

A89 – “Emerging Concepts in Chronic Thromboembolic Pulmonary Hypertension”
Educational Grant Support: Bayer US

A92 – “From Principles to Practice: Exploring Mechanistic Knowledge to Advance Clinical Care”
Educational Grant Support: AstraZeneca LP, GlaxoSmithKline, Sunovion Pharmaceuticals Inc., Vertex Pharmaceuticals Inc.

PCC1 – “Pediatric Clinical Core Curriculum: Cystic Fibrosis”
Educational Grant Support: Gilead Sciences, Inc., Vertex Pharmaceuticals Inc.

Monday, May 21, 2018

B1 – “Clinical Year in Review 2”
Educational Grant Support: AstraZeneca LP, GlaxoSmithKline, Sunovion Pharmaceuticals Inc., Sanofi Genzyme and Regeneron Pharmaceuticals

B2 – “Interstitial Lung Disease (ILD), Idiopathic Interstitial Pneumonia (IIP) and Hypersensitivity Pneumonitis (HP): Controversies in Management: A Pro/Con Debate”
Educational Grant Support: Boehringer Ingelheim Pharmaceuticals, Inc.

B7 – “Genetics, Epigenetics, and Genomics of Childhood Lung Diseases”
Educational Grant Support: Vertex Pharmaceuticals Inc.

B8 – “Nontuberculosis Mycobacteria Infection: Current Knowledge and Recent Advances”
Educational Grant Support: Insmed Incorporated

B9 – “TH17 Cells: Friend, Foe or Both in Chronic Lung Diseases”
Educational Grant Support: GlaxoSmithKline, Sanofi Genzyme and Regeneron Pharmaceuticals

B10 – “Lung Cancer Screening: Who's In and Who's Out? A Pro/Con Debate”
Educational Grant Support: AstraZeneca LP

B82 – “Controversies in the Diagnosis and Treatment of COPD”
Educational Grant Support: AstraZeneca LP, GlaxoSmithKline, Sunovion Pharmaceuticals Inc.

B88 – “Just Do It: Reducing Pediatric Respiratory Health Disparities”
Educational Grant Support: GlaxoSmithKline, Sanofi Genzyme and Regeneron Pharmaceuticals, Vertex Pharmaceuticals Inc.

B89 – “Not Just the Lungs: PAH as a Systemic Vascular Disorder”
Educational Grant Support: Actelion Pharmaceuticals US, Inc., Bayer US

B92 – “AJRCCM in 2018”
Educational Grant Support: AstraZeneca LP, Boehringer Ingelheim Pharmaceuticals, Inc., GlaxoSmithKline, Sanofi Genzyme and Regeneron Pharmaceuticals, Sunovion Pharmaceuticals Inc.

Tuesday, May 22, 2018

C1 – “Clinical Year in Review 3”
Educational Grant Support: Vertex Pharmaceuticals Inc.

C2 – “Interstitial Lung Disease from Cradle to Grave”
Educational Grant Support: Boehringer Ingelheim Pharmaceuticals, Inc.

C6 – “COPD Progression - Culprits and Modifiers”
Educational Grant Support: AstraZeneca LP, GlaxoSmithKline, Sunovion Pharmaceuticals Inc.

C8 – “Translational Immunology and Lung Disease: Integrating Pathobiology to Therapy”
Educational Grant Support: Boehringer Ingelheim Pharmaceuticals, Inc., GlaxoSmithKline, Mallinckrodt Pharmaceuticals, Sanofi Genzyme and Regeneron Pharmaceuticals

C87 – “What's Old Is New Again: Repurposing Approved Medications for Novel Therapeutics in PAH - Early Clinical Studies”
Educational Grant Support: Actelion Pharmaceuticals US, Inc., Bayer US

C93 – “ATS Clinical Practice Guidelines: Practice on the Cutting Edge”
Educational Grant Support: AstraZeneca LP, GlaxoSmithKline, Sunovion Pharmaceuticals Inc.

WS6 – “Bronchoscopic Approach to the Peripheral Lung Nodule”
Educational Grant Support: AstraZeneca LP, Boston Scientific Corporation

Wednesday, May 23, 2018

D3 - “Women and Lung Disease”
Educational Grant Support: Actelion Pharmaceuticals US, Inc., AstraZeneca LP, Bayer US, Boehringer Ingelheim Pharmaceuticals, Inc., GlaxoSmithKline, Sanofi Genzyme and Regeneron Pharmaceuticals, Sunovion Pharmaceuticals Inc.

D9 – “Controversies in Clinical Pediatric Pulmonology”
Educational Grant Support: Vertex Pharmaceuticals Inc.

D10 – “Growing Up with Chronic Pulmonary Disease: Challenges in the Transition from Pediatric to Adult Focused Healthcare”
Educational Grant Support: Vertex Pharmaceuticals Inc.

D83 – “Clinical Trial Design in IPF”
Educational Grant Support: Boehringer Ingelheim Pharmaceuticals, Inc.

D87 – “To Each its Own: Single Cell MRNA Sequencing in Lung Development and Disease”
Educational Grant Support: AstraZeneca LP, Boehringer Ingelheim Pharmaceuticals, Inc.

D89 – “Long-Term Complications After Respiratory Infections”  
Educational Grant Support: Insmed Incorporated

CC5 – “Adult Clinical Core Curriculum: ILD and Parenchymal Lung Diseases”  
Educational Grant Support: Boehringer Ingelheim Pharmaceuticals, Inc.

CC6 – “Adult Clinical Core Curriculum: Neuromuscular Disease; ILD; Occupational/Environmental Disease; Drug Induced Lung Disease”  
Educational Grant Support: Boehringer Ingelheim Pharmaceuticals, Inc.